Ascent Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Ascent Group's GILD Position: Q3 2026 in Review
Ascent Group reduced its Gilead Sciences (GILD) stake by 11% in Q3 2026, selling an estimated $1.02M and leaving 56,100 shares worth $8.36M. The position accounts for 0.25% of the portfolio, ranked #83.
Ascent Group first reported a position in GILD in Q4 2021 and has held it in 20 quarters since. The position peaked at $8.67M in Q1 2026. 2,179 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Ascent Group held 56,100 shares of Gilead Sciences worth $8.36M as of Q3 2026.
- Ascent Group sold 7,256 Gilead Sciences shares in Q3 2026, an estimated $1.02M.
- Gilead Sciences made up 0.25% of Ascent Group's portfolio in Q3 2026, its #83 holding.
- Ascent Group first reported a position in Gilead Sciences in Q4 2021 and has held it in 20 quarters since.
- Ascent Group's Gilead Sciences position peaked at $8.67M in Q1 2026.
- 2,179 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Ascent Group's 13F filing for Q3 2026, filed 30 Oct 2026.